← Browse by Condition
Medical Condition
locally advanced gastroesophageal junction adenocarcinoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 1, Phase 2
NCT05651594 Phase 2
Recruiting
Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma
Enrollment
40 pts
Location
United States
Sponsor
Roswell Park Cancer Institute
NCT05269381 Phase 1, Phase 2
Recruiting
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
Enrollment
132 pts
Location
United States
Sponsor
Mayo Clinic